KR100657094B1 - 티오에테르기를 술폭사이드기로 산화하는 방법 - Google Patents

티오에테르기를 술폭사이드기로 산화하는 방법 Download PDF

Info

Publication number
KR100657094B1
KR100657094B1 KR1020027011987A KR20027011987A KR100657094B1 KR 100657094 B1 KR100657094 B1 KR 100657094B1 KR 1020027011987 A KR1020027011987 A KR 1020027011987A KR 20027011987 A KR20027011987 A KR 20027011987A KR 100657094 B1 KR100657094 B1 KR 100657094B1
Authority
KR
South Korea
Prior art keywords
thioether
group
methyl
carbon atoms
ammonium molybdate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020027011987A
Other languages
English (en)
Korean (ko)
Other versions
KR20030007461A (ko
Inventor
라몬 베렌구에르마이모
줄리오 캄폰파르도
라우라 코피
Original Assignee
에스티브 퀴미카 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에스티브 퀴미카 에스.에이. filed Critical 에스티브 퀴미카 에스.에이.
Publication of KR20030007461A publication Critical patent/KR20030007461A/ko
Application granted granted Critical
Publication of KR100657094B1 publication Critical patent/KR100657094B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
KR1020027011987A 2000-03-13 2001-03-08 티오에테르기를 술폭사이드기로 산화하는 방법 Expired - Fee Related KR100657094B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200000595 2000-03-13
ES200000595A ES2163372B1 (es) 2000-03-13 2000-03-13 Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
PCT/ES2001/000088 WO2001068594A1 (es) 2000-03-13 2001-03-08 Procedimiento de oxidacion de un grupo tioeter a sulfoxido

Publications (2)

Publication Number Publication Date
KR20030007461A KR20030007461A (ko) 2003-01-23
KR100657094B1 true KR100657094B1 (ko) 2006-12-12

Family

ID=8492674

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020027011987A Expired - Fee Related KR100657094B1 (ko) 2000-03-13 2001-03-08 티오에테르기를 술폭사이드기로 산화하는 방법

Country Status (16)

Country Link
US (1) US6603009B2 (enExample)
EP (1) EP1270555B1 (enExample)
JP (1) JP5041646B2 (enExample)
KR (1) KR100657094B1 (enExample)
CN (1) CN1229341C (enExample)
AT (1) ATE274492T1 (enExample)
AU (2) AU2001237452B9 (enExample)
CA (1) CA2402635C (enExample)
DE (1) DE60105139T2 (enExample)
ES (2) ES2163372B1 (enExample)
HU (1) HUP0301885A2 (enExample)
MX (1) MXPA02008961A (enExample)
NO (1) NO20024239L (enExample)
NZ (1) NZ521071A (enExample)
PT (1) PT1270555E (enExample)
WO (1) WO2001068594A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1363901A4 (en) * 2001-02-02 2005-08-31 Teva Pharma PROCESS FOR PREPARING SUBSTITUTED 2- (2-PYRIDYLMETHYL) SULFINYL-1H-BENZIMIDAZOLENE
KR100464174B1 (ko) * 2002-03-06 2005-01-03 코오롱유화주식회사 설피닐 벤즈이미다졸 유도체의 제조방법
EP1501824B1 (en) 2002-08-21 2007-10-10 Teva Pharmaceutical Industries Ltd A method for the purification of lansoprazole
EP1465890B1 (en) 2002-11-18 2007-04-04 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
EP1485373A1 (en) 2003-02-05 2004-12-15 Teva Pharmaceutical Industries Limited Method of stabilizing lansoprazole
CA2528993A1 (en) 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
AU2005268056B2 (en) 2004-08-06 2008-07-31 Eisai R&D Management Co., Ltd. Salts of benzimidazole derivative with amines and process for production thereof
PL1802584T3 (pl) 2004-10-11 2010-03-31 Ranbaxy Laboratories Ltd Sposób wytwarzania podstawionych sulfotlenków
KR100771659B1 (ko) 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
CN1919844B (zh) * 2006-09-01 2010-05-12 武汉工程大学 水相氧化合成兰索拉唑的方法
WO2009066309A2 (en) * 2007-07-12 2009-05-28 Cadila Healthcare Limited Process for preparation of omeprazole
WO2009010937A1 (en) * 2007-07-17 2009-01-22 Ranbaxy Laboratories Limited Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
CN102161633A (zh) * 2011-02-22 2011-08-24 苏州科同生物医药科技有限公司 亚砜类有机化合物的制备方法
CN103044399B (zh) * 2011-10-12 2014-08-06 北大方正集团有限公司 一种雷贝拉唑及其钠盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2060541B1 (es) * 1993-02-26 1995-11-16 Vinas Lab Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
EP1300406B1 (en) * 1997-07-11 2004-10-06 Eisai Co., Ltd. Method for producing pyridine compound
US6437189B1 (en) * 1997-12-12 2002-08-20 Bayer Corporation Synthesis of sulfoxides via selective oxidation of sulfides with a perborate or a percarbonate
ES2185459B1 (es) * 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.

Also Published As

Publication number Publication date
PT1270555E (pt) 2005-01-31
NO20024239D0 (no) 2002-09-05
ES2227145T3 (es) 2005-04-01
HUP0301885A2 (hu) 2003-09-29
CA2402635C (en) 2008-07-08
ES2163372B1 (es) 2003-05-01
ATE274492T1 (de) 2004-09-15
DE60105139D1 (de) 2004-09-30
US20030028030A1 (en) 2003-02-06
CN1418188A (zh) 2003-05-14
JP5041646B2 (ja) 2012-10-03
WO2001068594A1 (es) 2001-09-20
AU2001237452B9 (en) 2005-01-27
DE60105139T2 (de) 2005-09-15
CA2402635A1 (en) 2001-09-20
CN1229341C (zh) 2005-11-30
ES2163372A1 (es) 2002-01-16
NO20024239L (no) 2002-09-05
AU3745201A (en) 2001-09-24
AU2001237452B2 (en) 2005-01-13
NZ521071A (en) 2004-05-28
MXPA02008961A (es) 2004-10-15
EP1270555A1 (en) 2003-01-02
US6603009B2 (en) 2003-08-05
JP2003527370A (ja) 2003-09-16
EP1270555B1 (en) 2004-08-25
KR20030007461A (ko) 2003-01-23

Similar Documents

Publication Publication Date Title
KR100657094B1 (ko) 티오에테르기를 술폭사이드기로 산화하는 방법
JP4320250B2 (ja) ベンズイミダゾール型化合物の製造のための改良法
US20080091024A1 (en) Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
AU2002321204A1 (en) Improved process for preparing benzimidazole-type compounds
JP2003527370A5 (enExample)
US20040138466A1 (en) Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
HK1055942A (en) Procedure for oxidizing of a thioether group to a sulfoxide group
AU2002240242A1 (en) Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles
KR20020026016A (ko) 금속촉매를 이용한 설피닐 화합물의 제조방법

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20100507

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20111207

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20111207